DiagnaMed Holdings Corp. · CSE:DMED

DiagnaMed — Investor Presentation (January 2024)

15 slides from DiagnaMed's investor presentation, January 2024

  1. Slide 1: Generative AI Brain Health Solutions Corporate Presentation

    Generative AI Corporate Presentation Brain Health Solutions January 2024 DiagnaMed Holdings Corp. 82 Richmond Street East Toronto, ON M5C 1P1 e. info@diagnamed.com t. 416-800-2684

  2. Slide 2: Summary

    Summary Commercializing CERVAI™, a consumer brain health AI solution that estimates brain age and provides a brain health score Targeting over 2 billion people globally with mental health and neurological disorders Growing commerical and clinical partnerships Multiple value creating milestones in 20

  3. Slide 3: Health Tech Valuations

    Health Tech Valuations $180M $70M $65M $2M NEO: VERS TSX: AIDX TSXV: PINK CSE: DMED January 16, 2024 (Values rounded) Currency CAD CSE: DMED | OTCQB: DGNMF

  4. Slide 4: Digital Brain Health Market

    Digital +1 Billion Mental Health Brain Health Market over $375 Billion +1 Billon Neurodegenerative by 2031* *Source: TMR Report https://www.prnewswire.com/news-releases/digital-brain-health-market-to-exceed- value-of-us-382-9-bn-by-2031-tmr-report-301664843.html CSE: DMED | OTCQB: DGNMF

  5. Slide 5: Problem

    Problem I have a family No one-fits-all solution for history of Alzheimer's estimating, monitoring and I'm feeling depressed I keep on improving brain health. forgetting things ----- Expensive equipment and unproven detection methods. ----- Require a reliable and scalable solution. CSE: DMED | OTCQB

  6. Slide 6: Our Solution

    Our Solution CERVAI™ Brain Health Platform Estimating Brain Age Validation studies performed Providing Brain Health Risk Score Monitoring overall Brain Health Implementing support solutions Utilizing in clinic and home CSE: DMED | OTCQB: DGNMF

  7. Slide 7: CERVAI Features

    CERVAI™ Features Brain Age Brain Health Estimation Risk Score Use of novel Evaluate overall brain electroencephalogram health, output a patient (EEG) device and ML/AI risk score, and provide techniques for predicting actionable data. and monitoring brain age. Brain Health CERVAI™ Brain Health Brain

  8. Slide 8: CERVAI Journey

    CERVAI™ Journey 1 How is my brain health? 2 3 1 2 3 TAKING CONTROL ESTIMATING BRAIN AGE BRAIN HEALTH ASSESSMENT Schedule a visit to a CERVAI™ Place a safe and easy to use EEG Take an online brain health provider if curious or concerned headset for EEG collection assessment about your brain health 4

  9. Slide 9: Business Model

    Business Model License Fees Place in up to 25,000 provider locations in North America (Primary care physicians, psychiatric & neurology clinics, senior care homes, pharmacies, sport teams) Recurring Visits Programs offered up to 4 visits per year App Subscriptions Monthly subscription to virtual cli

  10. Slide 10: Our Growth Plan

    Our Growth Plan 2024 H2-2024 H1-2024 Unlock new uses of Expand commercialization CERVAI™ CERVAI™ Clinical diagnostic tool for Grow provider sites, consumer monitoring and screening of and patient awareness mental health, neurological and brain injuries Establish CERVAI™ provider network in Canada an

  11. Slide 11: Expected Milestones 2024

    Expected Milestones 2024 Q1: Commerical launch of CERVAI™ in Canada Q2: Commercial launch of CERVAI™ in the U.S. Q3: Commercial launch of CERVAI™ in Europe Q3: Clinical study to support insurance reimbursement Q4: Multiple international commercial partnerships for CERVAI™ CSE: DMED | OTCQB: DGNMF

  12. Slide 12: Partnerships

    Partnerships Brain Age Brain Health Development Team CSE: DMED | OTCQB: DGNMF

  13. Slide 13: Team

    Team Management Advisors Fabio Chianelli Dr. John Kounios, PhD Founder, Chairman, and CEO Principal Researcher - Brain AGE Founder, CEO - PharmaTher Applied Cognitive & Brain Sciences Founder, President - Revive Thera Professor, Drexel University Jing Peng, CPA Dr. James E Galvin, M.D., M.P.H. Chief

  14. Slide 14: Financial Snapshot

    Financial 80,052,640 2,000,000 Common Shares outstanding Stock Options Snapshot ~ 21% Insider Ownership 37,382,226 Common Shares are subject to escrow 1/10th released at: November 8, 2023, 2024, 2025 May 8, 2024, 2025, 2026 2/10th released at: November 8, 2026 CSE: DMED | OTCQB: DGNMF

  15. Slide 15: Thank You

    THANK YOU info@diagnamed.com CSE: DMED | OTCQB: DGNMF

DiagnaMed Holdings — Investor Presentation (January 2024) on 6ix